152 related articles for article (PubMed ID: 36625814)
1. Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Hsu CH; Chen CH; Hsu NC
JAMA; 2023 Jan; 329(2):176-177. PubMed ID: 36625814
[No Abstract] [Full Text] [Related]
2. Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
DeMik DE; Mont MA; Dunbar M
JAMA; 2023 Jan; 329(2):177. PubMed ID: 36625816
[No Abstract] [Full Text] [Related]
3. Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty.
Hsu CC; Hsu CJ; Wei JC
JAMA; 2023 Jan; 329(2):176. PubMed ID: 36625815
[No Abstract] [Full Text] [Related]
4. Aspirin vs Enoxaparin and Symptomatic Venous Thromboembolism in Hip or Knee Arthroplasty-Reply.
Sidhu VS; Harris IA
JAMA; 2023 Jan; 329(2):177-178. PubMed ID: 36625812
[No Abstract] [Full Text] [Related]
5. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
[TBL] [Abstract][Full Text] [Related]
6. Enoxaparin Is Better Than Aspirin for the Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty.
Kulkarni NS
Am Fam Physician; 2023 Feb; 107(2):200-201. PubMed ID: 36791434
[No Abstract] [Full Text] [Related]
7. Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial.
CRISTAL Study Group
PLoS One; 2024; 19(4):e0298152. PubMed ID: 38626226
[TBL] [Abstract][Full Text] [Related]
8. Dabigatran etexilate for prevention of venous thromboembolism.
Eikelboom JE; Weitz JI
Thromb Haemost; 2009 Jan; 101(1):2-4. PubMed ID: 19132179
[No Abstract] [Full Text] [Related]
9. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of enoxaparin versus aspirin in the prevention of venous thromboembolism after total hip or knee arthroplasty: an analysis from the CRISTAL cluster-randomized trial.
CRISTAL Economic Analysis Study Group
Bone Joint J; 2024 Jun; 106-B(6):589-595. PubMed ID: 38821513
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
Duran A; Sengupta N; Diamantopoulos A; Forster F; Kwong L; Lees M
Pharmacoeconomics; 2012 Feb; 30(2):87-101. PubMed ID: 22187932
[TBL] [Abstract][Full Text] [Related]
12. Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.
Baumgartner C; Maselli J; Auerbach AD; Fang MC
J Gen Intern Med; 2019 Oct; 34(10):2038-2046. PubMed ID: 31236894
[TBL] [Abstract][Full Text] [Related]
13. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
14. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Chu JN; Maselli J; Auerbach AD; Fang MC
Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
[TBL] [Abstract][Full Text] [Related]
16. Prevention of postoperative venous thromboembolism in Japanese patients undergoing total hip or knee arthroplasty: two randomized, double-blind, placebo-controlled studies with three dosage regimens of enoxaparin.
Fuji T; Ochi T; Niwa S; Fujita S
J Orthop Sci; 2008 Sep; 13(5):442-51. PubMed ID: 18843459
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives. Epilogue.
Merli G
Am J Manag Care; 2011 Feb; 17(1 Suppl):S33. PubMed ID: 21548181
[No Abstract] [Full Text] [Related]
18. Prevention of venous thromboembolism after total joint arthroplasty: aspirin is enough for most patients.
Dalury D; Lonner J; Parvizi J
Am J Orthop (Belle Mead NJ); 2015 Feb; 44(2):59-60. PubMed ID: 25658072
[No Abstract] [Full Text] [Related]
19. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
[TBL] [Abstract][Full Text] [Related]
20. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
